Medicaid Expansion Increases Guideline-Concordant Treatment for Breast Cancer
Increase seen in receipt of guideline-concordant treatment for women newly diagnosed with HR-negative, HER2-positive breast cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.